192 related articles for article (PubMed ID: 17393020)
1. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
Bugert P; Pabinger I; Stamer K; Vormittag R; Skeate RC; Wahi MM; Panzer S
Thromb Haemost; 2007 Apr; 97(4):573-80. PubMed ID: 17393020
[TBL] [Abstract][Full Text] [Related]
2. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
[TBL] [Abstract][Full Text] [Related]
3. Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease.
Jilma-Stohlawetz P; Jilma B; Mannhalter C; Bencur P; Pabinger I; Vormittag R; Dunkler D; Panzer S
Ann Hematol; 2007 Oct; 86(10):719-25. PubMed ID: 17634946
[TBL] [Abstract][Full Text] [Related]
4. Circulating P-selectin and the risk of recurrent venous thromboembolism.
Kyrle PA; Hron G; Eichinger S; Wagner O
Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
Sailer T; Vormittag R; Zoghlami C; Koder S; Quehenberger P; Male C; Pabinger I
Thromb Res; 2007; 120(2):295-302. PubMed ID: 17328943
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM
Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467
[TBL] [Abstract][Full Text] [Related]
8. The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients.
Schallmoser K; Rosin C; Knittelfelder R; Sailer T; Ulrich S; Zoghlami C; Lehr S; Pabinger I; Panzer S
Thromb Haemost; 2005 Mar; 93(3):544-8. PubMed ID: 15735807
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus.
Nagy B; Csongrádi E; Bhattoa HP; Balogh I; Blaskó G; Paragh G; Kappelmayer J; Káplár M
Thromb Haemost; 2007 Jul; 98(1):186-91. PubMed ID: 17598012
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for thromboembolic events in renal failure.
D'Elia JA; Weinrauch LA; Gleason RE; Lipinska I; Lipinski B; Lee AT; Tofler GH
Int J Cardiol; 2005 May; 101(1):19-25. PubMed ID: 15860378
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
12. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism.
Panzer S; Rosales S; Gisslinger H; Jungbauer L; Kaider A; Knöbl P; Sillaber C; Pabinger I
Thromb Res; 2008; 121(4):573-9. PubMed ID: 17698171
[TBL] [Abstract][Full Text] [Related]
14. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
[TBL] [Abstract][Full Text] [Related]
15. Methionine synthase polymorphism A2756G is associated with susceptibility for thromboembolic events and altered B vitamin/thiol metabolism.
Yates Z; Lucock M
Haematologica; 2002 Jul; 87(7):751-6; discussion 756. PubMed ID: 12091127
[TBL] [Abstract][Full Text] [Related]
16. The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort.
Petri M
Thromb Res; 2004; 114(5-6):593-5. PubMed ID: 15507296
[TBL] [Abstract][Full Text] [Related]
17. Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism.
Jilma B; Kovar FM; Hron G; Endler G; Marsik CL; Eichinger S; Kyrle PA
Arch Intern Med; 2006 Aug 14-28; 166(15):1655-9. PubMed ID: 16908800
[TBL] [Abstract][Full Text] [Related]
18. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
19. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
Galli M; Finazzi G; Norbis F; Marziali S; Marchioli R; Barbui T
Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
[TBL] [Abstract][Full Text] [Related]
20. Platelet reactivity in patients with a history of obstructive prosthetic valve thrombosis.
Bouganim T; Shapira Y; Sagie A; Vaturi M; Battler A; Kornowski R; Lev EI
Am J Cardiol; 2009 Jun; 103(12):1760-3. PubMed ID: 19539089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
